-
1
-
-
0036805582
-
A phase III trial comparing chemotherapy plus either once a day radiotherapy (QD RT) or twice a day radiotherapy (BID RT) in stage III non-small cell lung cancer
-
Schild SE, Stella PJ, Geyer SM, et al. A phase III trial comparing chemotherapy plus either once a day radiotherapy (QD RT) or twice a day radiotherapy (BID RT) in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Physiol 2002;54:370-378
-
(2002)
Int J Radiat Oncol Biol Physiol
, vol.54
, pp. 370-378
-
-
Schild, S.E.1
Stella, P.J.2
Geyer, S.M.3
-
2
-
-
0141465153
-
The outcome of combined-modality therapy for stage III non-small cell lung cancer in the elderly
-
Schild SE, Stella PJ, Geyer SM, et al. The outcome of combined-modality therapy for stage III non-small cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-3206
-
(2003)
J Clin Oncol
, vol.21
, pp. 3201-3206
-
-
Schild, S.E.1
Stella, P.J.2
Geyer, S.M.3
-
3
-
-
0025009172
-
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer
-
Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-945
-
(1990)
N Engl J Med
, vol.323
, pp. 940-945
-
-
Dillman, R.O.1
Seagren, S.L.2
Propert, K.J.3
-
4
-
-
0026580034
-
Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
-
Schaake-Koning C, Dalesio O, Festen J, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524-530
-
(1992)
N Engl J Med
, vol.326
, pp. 524-530
-
-
Schaake-Koning, C.1
Dalesio, O.2
Festen, J.3
-
5
-
-
0032947757
-
Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
-
Clamon G, Herndon J, Cooper R, Chang AY, Rosenman J, Green MR. Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999;17:4-11
-
(1999)
J Clin Oncol
, vol.17
, pp. 4-11
-
-
Clamon, G.1
Herndon, J.2
Cooper, R.3
Chang, A.Y.4
Rosenman, J.5
Green, M.R.6
-
6
-
-
0032858243
-
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer
-
Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17:2692-2699
-
(1999)
J Clin Oncol
, vol.17
, pp. 2692-2699
-
-
Furuse, K.1
Fukuoka, M.2
Kawahara, M.3
-
7
-
-
0029077107
-
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805
-
Albain KS, Rush VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995;13:1880-1892
-
(1995)
J Clin Oncol
, vol.13
, pp. 1880-1892
-
-
Albain, K.S.1
Rush, V.W.2
Crowley, J.J.3
-
8
-
-
0037102282
-
Concurrent cisplatin, etoposide, and chest radiotherapy in pathological stage IIIB non-small cell lung cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
-
Albain KS, Crowley JJ, Gandara DR, et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathological stage IIIB non-small cell lung cancer: a Southwest Oncology Group Phase II Study, SWOG 9019. J Clin Oncol 2002; 20:3454-3460
-
(2002)
J Clin Oncol
, vol.20
, pp. 3454-3460
-
-
Albain, K.S.1
Crowley, J.J.2
Gandara, D.R.3
-
9
-
-
0038688474
-
Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small cell lung cancer: Phase II Southwest Oncology Group Study S9504
-
Gandara DR, Chansky K, Albain KS, et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small cell lung cancer: phase II Southwest Oncology Group Study S9504. J Clin Oncol 2003;21:2004-2010
-
(2003)
J Clin Oncol
, vol.21
, pp. 2004-2010
-
-
Gandara, D.R.1
Chansky, K.2
Albain, K.S.3
-
10
-
-
0037108701
-
Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer: Cancer and Leukemia Group B study 9431
-
Vokes EE, Miller AA, Green MR, et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer: Cancer and Leukemia Group B study 9431. J Clin Oncol 2002;20: 4191-4198
-
(2002)
J Clin Oncol
, vol.20
, pp. 4191-4198
-
-
Vokes, E.E.1
Miller, A.A.2
Green, M.R.3
-
11
-
-
0346236869
-
Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410
-
Curran WJ, Scott CB, Langer CJ, et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 [abstract 2499]. Proc Am Soc Clin Oncol 2003;22:621
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 621
-
-
Curran, W.J.1
Scott, C.B.2
Langer, C.J.3
-
12
-
-
10844240941
-
Induction chemotherapy followed by concomitant chemoradiotherapy versus CT/XRT alone for regionally advaned unresectable non-small cell lung cancer: Intial analysis of a randomized phase III trial
-
Vokes EE, Herndon JE, Kelley MJ, Watson D, Cicchetti MG, Green MR. Induction chemotherapy followed by concomitant chemoradiotherapy versus CT/XRT alone for regionally advaned unresectable non-small cell lung cancer: intial analysis of a randomized phase III trial [abstract 7005]. J Clin Oncol 2004;22:7005
-
(2004)
J Clin Oncol
, vol.22
, pp. 7005
-
-
Vokes, E.E.1
Herndon, J.E.2
Kelley, M.J.3
Watson, D.4
Cicchetti, M.G.5
Green, M.R.6
-
13
-
-
0028069090
-
Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer
-
Kubota K, Furuse K, Kawahara M, et al. Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer. J Clin Oncol 1994;12:1547-1552
-
(1994)
J Clin Oncol
, vol.12
, pp. 1547-1552
-
-
Kubota, K.1
Furuse, K.2
Kawahara, M.3
-
14
-
-
0033179899
-
Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomized multicenter trial
-
Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicenter trial. Radiother Oncol 1999;52:137-148
-
(1999)
Radiother Oncol
, vol.52
, pp. 137-148
-
-
Saunders, M.1
Dische, S.2
Barrett, A.3
Harvey, A.4
Griffiths, G.5
Parmar, M.6
-
15
-
-
17744391075
-
Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)
-
Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group trial 9416 (Intergroup trial 0160). J Thorac Cardiovasc Surg 2001;121:472-483
-
(2001)
J Thorac Cardiovasc Surg
, vol.121
, pp. 472-483
-
-
Rusch, V.W.1
Giroux, D.J.2
Kraut, M.J.3
|